Inactive Instrument

Analyst Reco. Depomed Inc Nasdaq

Equities

Lake Street Adjusts Assertio Therapeutics' Price Target to $3 From $4, Maintains Buy Rating	Mar. 12	MT
BWS Financial Adjusts Assertio Therapeutics' Price Target to $10 From $8, Keeps Buy Rating	23-05-10	MT
Lake Street Adjusts Assertio Therapeutics' Price Target to $9 From $8, Keeps Buy Rating	23-05-10	MT
BWS Financial Adjusts Price Target on Assertio Therapeutics to $8 From $6, Maintains Buy Rating	23-03-03	MT
Lake Street Initiates Assertio Therapeutics at Buy Rating With $7 Price Target	22-11-07	MT
BWS Financial Initiates Assertio Therapeutics at Buy, $6 Price Target	22-05-18	MT
ASSERTIO : Gabelli Upgrades Assertio Therapeutics to Buy From Hold	21-04-09	MT

No results for this search